196 related articles for article (PubMed ID: 1560043)
21. Thrombin receptor 14-amino acid peptide binds to endothelial cells and stimulates calcium transients.
Tiruppathi C; Lum H; Andersen TT; Fenton JW; Malik AB
Am J Physiol; 1992 Nov; 263(5 Pt 1):L595-601. PubMed ID: 1332502
[TBL] [Abstract][Full Text] [Related]
22. The tethered ligand receptor is the responsible receptor for the thrombin induced release of von Willebrand factor from endothelial cells (HUVEC).
Storck J; Küsters B; Zimmermann ER
Thromb Res; 1995 Feb; 77(3):249-58. PubMed ID: 7740517
[TBL] [Abstract][Full Text] [Related]
23. Effects of magnesium on prostacyclin synthesis and intracellular free calcium concentration in vascular cells.
Satake K; Lee JD; Shimizu H; Uzui H; Mitsuke Y; Yue H; Ueda T
Magnes Res; 2004 Mar; 17(1):20-7. PubMed ID: 15083565
[TBL] [Abstract][Full Text] [Related]
24. Hirudin-based peptides block the inflammatory effects of thrombin on endothelial cells.
Prescott SM; Seeger AR; Zimmerman GA; McIntyre TM; Maraganore JM
J Biol Chem; 1990 Jun; 265(17):9614-6. PubMed ID: 2112544
[TBL] [Abstract][Full Text] [Related]
25. Evidence for thrombin enhancement of fibrin polymerization that is independent of its catalytic activity.
Kaminski M; Siebenlist KR; Mosesson MW
J Lab Clin Med; 1991 Mar; 117(3):218-25. PubMed ID: 2002278
[TBL] [Abstract][Full Text] [Related]
26. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
Chang JY
Biochemistry; 1991 Jul; 30(27):6656-61. PubMed ID: 2065053
[TBL] [Abstract][Full Text] [Related]
27. Modulation of the enzymatic activity of alpha-thrombin by polyanions: consequences on intrinsic activation of factor V and factor VIII.
Ofosu FA
Haemostasis; 1991; 21(4):240-7. PubMed ID: 1794749
[TBL] [Abstract][Full Text] [Related]
28. Combined blockade of thrombin anion binding exosite-1 and PAR4 produces synergistic antiplatelet effect in human platelets.
Wu CC; Wang WY; Wei CK; Teng CM
Thromb Haemost; 2011 Jan; 105(1):88-95. PubMed ID: 21057701
[TBL] [Abstract][Full Text] [Related]
29. The correlation between rises in intracellular calcium and PGI2 production in cultured vascular endothelial cells.
Watanabe K; Lam G; Jaffe EA
Prostaglandins Leukot Essent Fatty Acids; 1992 Jul; 46(3):211-4. PubMed ID: 1508953
[TBL] [Abstract][Full Text] [Related]
30. An autoantibody directed against human thrombin anion-binding exosite in a patient with arterial thrombosis: effects on platelets, endothelial cells, and protein C activation.
Arnaud E; Lafay M; Gaussem P; Picard V; Jandrot-Perrus M; Aiach M; Rendu F
Blood; 1994 Sep; 84(6):1843-50. PubMed ID: 8080990
[TBL] [Abstract][Full Text] [Related]
31. The platelet high affinity binding site for thrombin mimics hirudin, modulates thrombin-induced platelet activation, and is distinct from the glycoprotein Ib-IX-V complex.
Hayes KL; Tracy PB
J Biol Chem; 1999 Jan; 274(2):972-80. PubMed ID: 9873039
[TBL] [Abstract][Full Text] [Related]
32. [The critical role of the interaction of anion-binding thrombin exosite with complementary segment of the Aalpha-chain of fibrinogen in detecting high specificity of the enzyme].
Sereĭskaia AA; Smirnova IV; Karabut LV; Chetyrkina SN
Biokhimiia; 1994 Mar; 59(3):360-7. PubMed ID: 8180269
[TBL] [Abstract][Full Text] [Related]
33. Structure-activity relationships of recombinant hirudins.
Stürzebecher J; Walsmann P
Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
[TBL] [Abstract][Full Text] [Related]
34. Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells.
Horie S; Ishii H; Kazama M
Thromb Res; 1990 Sep; 59(6):895-904. PubMed ID: 2175954
[TBL] [Abstract][Full Text] [Related]
35. Allosteric changes in thrombin's activity produced by peptides corresponding to segments of natural inhibitors and substrates.
Hortin GL; Trimpe BL
J Biol Chem; 1991 Apr; 266(11):6866-71. PubMed ID: 1849894
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of thrombin-catalyzed factor V activation by bothrojaracin.
Arocas V; Lemaire C; Bouton MC; Bezeaud A; Bon C; Guillin MC; Jandrot-Perrus M
Thromb Haemost; 1998 Jun; 79(6):1157-61. PubMed ID: 9657441
[TBL] [Abstract][Full Text] [Related]
37. IL-1 and related cytokines enhance thrombin-stimulated PGI2 production in cultured endothelial cells without affecting thrombin-stimulated von Willebrand factor secretion or platelet-activating factor biosynthesis.
Zavoico GB; Ewenstein BM; Schafer AI; Pober JS
J Immunol; 1989 Jun; 142(11):3993-9. PubMed ID: 2497185
[TBL] [Abstract][Full Text] [Related]
38. The dual role of thrombin's anion-binding exosite-I in the recognition and cleavage of the protease-activated receptor 1.
Myles T; Le Bonniec BF; Stone SR
Eur J Biochem; 2001 Jan; 268(1):70-7. PubMed ID: 11121104
[TBL] [Abstract][Full Text] [Related]
39. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
Chang JY; Ngai PK; Rink H; Dennis S; Schlaeppi JM
FEBS Lett; 1990 Feb; 261(2):287-90. PubMed ID: 2107100
[TBL] [Abstract][Full Text] [Related]
40. Bothrojaracin: a potent two-site-directed thrombin inhibitor.
Arocas V; Zingali RB; Guillin MC; Bon C; Jandrot-Perrus M
Biochemistry; 1996 Jul; 35(28):9083-9. PubMed ID: 8703912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
